345 related articles for article (PubMed ID: 21888063)
1. [Advances in preservative-free glaucoma drops].
Stefan C; Pop A; Cojocaru I
Oftalmologia; 2011; 55(2):3-6. PubMed ID: 21888063
[TBL] [Abstract][Full Text] [Related]
2. [Glaucoma and ocular surface].
Stefan C; Cojocaru I; Pop A
Oftalmologia; 2011; 55(1):30-3. PubMed ID: 21774383
[TBL] [Abstract][Full Text] [Related]
3. IOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucoma.
Hommer A; Mohammed Ramez O; Burchert M; Kimmich F
Curr Med Res Opin; 2010 Aug; 26(8):1905-13. PubMed ID: 20553122
[TBL] [Abstract][Full Text] [Related]
4. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma.
Baudouin C
Acta Ophthalmol; 2008 Nov; 86(7):716-26. PubMed ID: 18537937
[TBL] [Abstract][Full Text] [Related]
5. [Clinical tolerance of antiglaucoma eyedrops with and without a preservative. Results of an unpublished survey in Europe].
Levrat F; Pisella PJ; Baudouin C
J Fr Ophtalmol; 1999 Mar; 22(2):186-91. PubMed ID: 10327349
[TBL] [Abstract][Full Text] [Related]
6. The effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: a review.
Yee RW
Curr Opin Ophthalmol; 2007 Mar; 18(2):134-9. PubMed ID: 17301615
[TBL] [Abstract][Full Text] [Related]
7. [Antiglaucoma drops--with or without preservatives].
Zemba M
Oftalmologia; 2009; 53(2):26-30. PubMed ID: 19697836
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of failure in glaucoma filtering surgery: a consequence of antiglaucomatous drugs?
Baudouin C
Int J Clin Pharmacol Res; 1996; 16(1):29-41. PubMed ID: 9001927
[TBL] [Abstract][Full Text] [Related]
9. [Influence on ocular surface and intraocular pressure of switching from preservative-containing to preservative-free carteolol hydrochloride ophthalmic solution].
Chikama T; Araie M; Nishida T
Nippon Ganka Gakkai Zasshi; 2013 May; 117(5):419-26. PubMed ID: 23855234
[No Abstract] [Full Text] [Related]
10. [Glaucoma and dry eye. Current concepts and future perspectives].
Steven P; Cursiefen C
Ophthalmologe; 2013 Dec; 110(12):1155-9. PubMed ID: 24129917
[TBL] [Abstract][Full Text] [Related]
11. An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology.
Martone G; Frezzotti P; Tosi GM; Traversi C; Mittica V; Malandrini A; Pichierri P; Balestrazzi A; Motolese PA; Motolese I; Motolese E
Am J Ophthalmol; 2009 Apr; 147(4):725-735.e1. PubMed ID: 19181302
[TBL] [Abstract][Full Text] [Related]
12. [Managing treatment side effects: the respective roles of the active ingredient and the preservative].
Aptel F; Denis P; Baudouin C
J Fr Ophtalmol; 2011 Jun; 34(6):409-12. PubMed ID: 21511364
[TBL] [Abstract][Full Text] [Related]
13. Preservative-free treatment in glaucoma: who, when, and why.
Stalmans I; Sunaric Mégevand G; Cordeiro MF; Hommer A; Rossetti L; Goñi F; Heijl A; Bron A
Eur J Ophthalmol; 2013; 23(4):518-25. PubMed ID: 23483513
[TBL] [Abstract][Full Text] [Related]
14. [The influence of ocular surface diseases in the management of glaucoma].
Van Went C; Brasnu E; Hamard P; Baudouin C; Labbé A
J Fr Ophtalmol; 2011 Apr; 34(4):230-7. PubMed ID: 21439676
[TBL] [Abstract][Full Text] [Related]
15. [The deleterious effect of certain surface active agents on the ocular surface].
Ravet O
Bull Soc Belge Ophtalmol; 2007; (304):145-9. PubMed ID: 17718239
[TBL] [Abstract][Full Text] [Related]
16. Preservative exposure and surgical outcomes in glaucoma patients: The PESO study.
Boimer C; Birt CM
J Glaucoma; 2013 Dec; 22(9):730-5. PubMed ID: 23524856
[TBL] [Abstract][Full Text] [Related]
17. Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives.
Ramli N; Supramaniam G; Samsudin A; Juana A; Zahari M; Choo MM
Optom Vis Sci; 2015 Sep; 92(9):e222-6. PubMed ID: 25730335
[TBL] [Abstract][Full Text] [Related]
18. How ocular surface disease impacts the glaucoma treatment outcome.
Kaštelan S; Tomić M; Metež Soldo K; Salopek-Rabatić J
Biomed Res Int; 2013; 2013():696328. PubMed ID: 24224176
[TBL] [Abstract][Full Text] [Related]
19. Are preservatives necessary to improve efficacy of some glaucoma drops?
Irkec M; Bozkurt B; Mocan MC
Br J Ophthalmol; 2013 Dec; 97(12):1493-4. PubMed ID: 24216677
[No Abstract] [Full Text] [Related]
20. [Effects of preservatives in anti-glaucoma agents on the ocular surface].
Potop V
Oftalmologia; 2009; 53(2):92-6. PubMed ID: 19697847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
